Thromb Haemost 1994; 72(01): 084-088
DOI: 10.1055/s-0038-1648816
Original Article
Schattauer GmbH Stuttgart

Effect of Concentration of Trisodium Citrate Anticoagulant on Calculation of the International Normalised Ratio and the International Sensitivity Index of Thromboplastin

E M Duncan
The Haemostasis Section, Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
,
C R Casey
The Haemostasis Section, Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
,
B M Duncan
The Haemostasis Section, Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
,
J V Lloyd
The Haemostasis Section, Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
› Author Affiliations
Further Information

Publication History

Received 02 September 1993

Accepted after resubmission 01 March 1994

Publication Date:
12 July 2018 (online)

Summary

The aim of this study was to determine whether the concentration of trisodium citrate used to anticoagulate blood has an effect on the INR of the sample and the ISI of the thromboplastin. Five thromboplastins including and Australian reference material were used to measure the prothrombin time of normal and patient samples collected into two concentrations of trisodium citrate - 109 mM and 129 mM. There was no effect of citrate concentration on the INRs determined with the reference material. However for the other four thromboplastins there was a significant difference between INRs for the two citrate groups. The prothrombin times of the samples collected into 129 mM were longer than those collected into 109 mM. This difference was only slight in normal plasma but more marked in patients receiving oral anticoagulants, causing the INRs for patient plasmas collected into 129 mM citrate to be higher then the corresponding samples collected into 109 mM citrate.

From orthogonal regression of log prothrombin times by the reference method against each thromboplastin, we found that the ISI for each thromboplastin was approximately 10% lower when determined with samples collected into 129 mM citrate than with samples collected into 109 mM. These results suggest that the concentration of trisodium citrate used for collection of blood samples can affect the calculation of the INR and the calibration of the ISI of thromboplastin. This was found both for commercial thromboplastins prepared by tissue extraction and for a recombinant tissue factor.

 
  • References

  • 1 Loeliger EA, van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost 1985; 53: 148-154
  • 2 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253). Thromb Haemost 1984; 52: 336-342
  • 3 Hermans J, van den Besselaar AMHP, Loeliger EA, van der Velde EA. A collaborative study of reference materials for thromboplastins. Thromb Haemost 1983; 50: 712-717
  • 4 van den Besselaar AMHP, Bertina RM. Multi-center study of thromboplastin calibration precision - influence of reagent species, composition, and international sensitivity index (ISI). Thromb Haemost 1993; 69: 35-40
  • 5 van den Besselaar AMPH, Lewis SM, Mannucci PM, Poller L. Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. Thromb Haemost 1993; 69: 85
  • 6 Poggio M, van den Besselaar AMPH, van der Velde EA, Bertina RM. The effect of some instruments for prothrombin time testing on the international sensitivity index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemost 1989; 62: 868-874
  • 7 Ray MJ, Smith IR. The dependence of the international sensitivity index on the coagulometer used to perform the prothrombin time. Thromb Haemost 1990; 63: 424-429
  • 8 Chantarangkul V, Tripodi A, Mannucci PM. The effect of instrumentation on thromboplastin calibration. Thromb Haemost 1992; 67: 588-589
  • 9 WHO Expert Committee on Biological Standardization. Thirty-third Report. WHO Tech Rep Ser 1983; 687: 81-105
  • 10 Tripodi A, Arbini A, Chantarangkul V, Manucci PM. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test. Thromb Haemost 1992; 67: 42-45
  • 11 Ingram GIC, Hills M. Reference method for the one-stage prothrombin time test on human blood. Thromb Haemost 1976; 36: 237-238
  • 12 Moriarty HT, Lam-Po-Tang PR, Anastas N. Comparison of thromboplastins using the ISI and INR system. Pathology 1990; 22: 71-76
  • 13 Loeliger EA, van den Besselaar T, Hermans J, van der Velde EA. Technical notes about orthogonal regression lines. In: BCR Information. The certification of three reference materials for thromboplastins, BCR No. 147, 148 and 149 Commission of the European Communities; Brussels: 1984: 46-48
  • 14 Bailey NTJ. Regression Analysis. In: Statistical Methods in Biology Hodder and Stoughton Ltd; London: 1975: 91-100
  • 15 Ingram GIC, Hills M. The prothrombin time test: Effect of varying citrate concentration. Thromb Haemost 1976; 36: 230-236